A lot of evidence supports the existence of a monoclonal origin for pituita
ry tumors, and several genetic alterations have already been confirmed as n
ecessary or sufficient for unrestrained cellular growth and pituitary funct
ion. The p53 gene, a known tumor-suppressor gene (TSG), encodes a protein t
hat exerts antiproliferative effects such as cell-growth arrest and apoptos
is in response to several types of stimuli. In fact, several human cancers
are believed to be caused by p53 mutations. In the case of pituitary tumors
, p53 protein accumulation has been described in ACTH-secreting pituitary a
denomas. Since increased amounts of the p53 protein are often related to mu
tations of its gene, we decided to explore the existence of p53 mutations i
n the tumor tissues of 9 patients bearing non-invasive corticotropinomas, e
xcised by the transphenoidal route. We screened mutations in exons 5 to 8 o
f the p53 gene by the PCR-SSCP analysis. We were not able to find any mutat
ion in the exons investigated: Our results are in close accordance with tho
se obtained previously for other types of pituitary tumors.